HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma.

Abstract
Pheochromocytoma (PHEO), a rare catecholamine producing tumor arising from the chromaffin cells, may occurs sporadically (76%-80%) or as part of inherited syndromes (20%-24%). Angiogenesis is a fundamental step in tumor proliferation and vascular endothelial growth factor (VEGF-A) is the most well-characterized angiogenic factor. The role of angiogenic markers in PHEO is not fully understood; investigations were therefore made to evaluate the expression of VEGF-A and its receptors in PHEO and correlate to clinical parameters. Twenty-nine samples of PHEO were evaluated for VEGF-A, VEGF receptor-1 (VEGFR-1) VEGFR-2 expression and microvessel density (MVD) by immunohistochemistry. Clinical data were reviewed in medical records. The mean age of patients was 38±14 years, and 69% were woman. VEGF-A, VEGFR-1 and VEGFR-2 staining were detected in nearly all PHEO samples. No significant correlation was observed between VEGF-A, VEGFR-1, VEGFR-2 expression or MVD and age at diagnosis, tumor size or sporadic and hereditary PHEO. However, the levels of expression of these molecules were significantly higher in malignant PHEO samples (p=0.027, p=0.003 and p=0.026, respectively).VEGF-A and its receptors were shown to be up-regulated in malignant PHEO, suggesting that these molecules might be considered as therapeutic targets for unresectable or metastatic tumors.
AuthorsCarla Vaz Ferreira, Débora Rodrigues Siqueira, Mírian Romitti, Lucieli Ceolin, Beatriz Assis Brasil, Luise Meurer, Clarissa Capp, Ana Luiza Maia
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 15 Issue 4 Pg. 5323-36 (Mar 26 2014) ISSN: 1422-0067 [Electronic] Switzerland
PMID24675699 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • KDR protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Adrenal Gland Neoplasms (blood supply, diagnosis)
  • Adrenal Medulla (blood supply, cytology, pathology)
  • Adult
  • Biomarkers, Tumor (biosynthesis)
  • Female
  • Humans
  • Male
  • Microvessels (physiology)
  • Multiple Endocrine Neoplasia Type 2a
  • Neovascularization, Pathologic
  • Pheochromocytoma (blood supply, diagnosis)
  • Vascular Endothelial Growth Factor A (biosynthesis)
  • Vascular Endothelial Growth Factor Receptor-1 (biosynthesis)
  • Vascular Endothelial Growth Factor Receptor-2 (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: